BMC Psychiatry

official impact factor 2.89

Open Access Pre-publication history

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Paul D Carey*, Bavanisha Vythilingum, Soraya Seedat, Jacqueline E Muller, Michael van Ameringen and Dan J Stein

BMC Psychiatry 2005, 5:5 doi:10.1186/1471-244X-5-5

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 12 Oct 2004
Reviewer's Report Lawrence Price 26 Oct 2004
Reviewer's Report lorrin koran 06 Nov 2004
Resubmission - Version 2 13 Dec 2004
Resubmission - Version 3 Manuscript 13 Dec 2004
Reviewer's Report lorrin koran 18 Dec 2004
Reviewer's Report Lawrence Price 23 Dec 2004
Resubmission - Version 4 Manuscript Author's comment 14 Jan 2005
Published 24 Jan 2005